Plant ID: NPO22532
Plant Latin Name: Coptis omeiensis
Taxonomy Genus: Coptis
Taxonomy Family: Ranunculaceae
NCBI TaxonomyDB:
261451
Plant-of-the-World-Online:
n.a.
China
GAA; | |
MAPT; LMNA; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 4.823E-07 | 5.251E-03 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.205E-06 | 8.750E-03 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 1.687E-06 | 9.186E-03 | CYP1A2, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 5.300E-06 | 1.649E-02 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 5.300E-06 | 1.649E-02 | CYP1A2, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 2.028E-05 | 5.521E-02 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006706; steroid catabolic process | 2.605E-05 | 5.672E-02 | CYP1A2, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 7.913E-05 | 1.566E-01 | CYP1A2, CYP3A4 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 4.614E-03 | 9.929E-01 | CYP1A2, CYP3A4, GAA, LMNA |
CC | GO:0044464; cell part | GO:0030673; axolemma | 4.960E-03 | 1.000E+00 | MAPT |
CC | GO:0043226; organelle | GO:0016607; nuclear speck | 5.189E-03 | 1.000E+00 | LMNA, MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 3.034E-05 | 6.068E-04 | CYP1A2, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.231E-04 | 7.810E-04 | CYP1A2, CYP3A4 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.547E-04 | 7.810E-04 | CYP1A2, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.744E-04 | 7.810E-04 | CYP1A2, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.953E-04 | 7.810E-04 | CYP1A2, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.464E-04 | 8.215E-04 | CYP1A2, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 4.116E-03 | 1.029E-02 | GAA, CYP1A2, CYP3A4 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.194E-02 | 2.388E-02 | CYP1A2 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 8.967E-03 | 1.993E-02 | GAA |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.499E-03 | 4.284E-03 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |